New York Mercantile Exchange › CRUDE OIL (E-MINI) Jun 2013/Jul 2013 Spread (NYMEX:QM.M13_N13.E)
-0.250 +0.025 (0.00%)
2013-05-20 11:00:03, 30 min delay
| Net Change | 0.025 |
|---|---|
| Volume | 217 |
| Contract High | -0.225 |
| Contract Low | -0.275 |
| Open Time | 18:00 |
| Settle Time | 17:46 |
|---|---|
| Time | 2013-05-20 11:00:03 |
| Contract High Date | 2013-05-20 |
| Contract Low Date | 2013-05-20 |
| Close Time | 17:15 |
Free Instant Analysis: Let our Trade Triangle technology, brought to you courtesy of our premium service MarketClub, instantly analyze any stock, futures or forex market for you. It’s free, It’s informative, It’s on the money.
Trader's Blog
Fundamentals Can Kill You If You're Not Careful!
56 minutes ago
In Precious Metals, Cash Flow Is King
2 hours, 9 minutes ago
Trade of the Week Review
8 hours ago
Today's Video Update: What Goes Up, Must Come Down...Right?
1 day ago
Today's News
AP Top Extended Financial Headlines At 2:53 p.m. EDT
1 hour, 53 minutes ago
Chrysler, regulators avoid showdown over Jeep models for fire risk; Chrysler will do recall Higher energy costs partly offset by cheaper food as US consumer prices rise just 0.1 percent
AP Top Financial News At 2:53 p.m. EDT
1 hour, 53 minutes ago
Chrysler agrees to recall of Jeeps at risk of fire Stocks move higher on home building, low inflation US consumer prices rise just 0.1 pct. in May
The ins and outs of G-8 summit promises
1 hour, 55 minutes ago
Group of Eight summit participants are powerful people: the leaders of the U.S., Russia, Britain, Germany, France, Italy, Canada and Japan, plus top officials from the European Union. But they only make promises. With that in mind, these are highlights of the summit's concluding statement Tuesday. ___
News Summary: Royalty Pharma lets Elan bid expire
1 hour, 55 minutes ago
TAKEOVER UPDATE: Royalty Pharma said Tuesday it has let its latest takeover bid for Irish drugmaker Elan lapse as it decided against pressing ahead with a court challenge of a requirement that it withdraw the offer. WHAT'S NEXT: Elan is exploring a sale of the company, and it has said Royalty can participate in its process. A Royalty spokesman declined to say whether the New York company will consider another offer.
